Urmia University of Medical Sciences Report issue

Academic/Hospital Phase 3
Founded: Urmia Iran (Islamic Republic of) (1980)

Organization Overview

First Clinical Trial
2012
NCT01530243
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Nutrition, School of Medicine, Urmia University of Medical Sciences | Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences | Urmia University of Medical Sciences

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 3)

Angina Pectoris (Phase 3)

Angina, Stable (Phase 3)

Angina, Unstable (Phase 3)

Heart Valve Diseases (Phase 3)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Syncope (Phase 3)

Syncope, Vasovagal (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 10